Myomo (MYO) Net Cash Flow (2016 - 2025)
Myomo's (MYO) quarterly Net Cash Flow came in at -$1.7 million in Q3 2025, down 249.28% YoY from $1.1 million in Q3 2024, and up 69.96% on a QoQ basis from -$5.6 million in Q2 2025.
Myomo (MYO) Net Cash Flow (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Net Cash Flow data on file, last reported at -$1.7 million in Q3 2025.
- Quarterly Net Cash Flow fell 249.28% year-over-year to -$1.7 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$11.9 million (down 166.59% YoY) and the FY2024 annual result came in at $17.9 million, up 1084.71% from the prior year.
- Net Cash Flow advanced to -$1.7 million in Q3 2025, from -$5.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $17.8 million in Q4 2024 to a low of -$5.6 million in Q2 2025.
- A 5-year average of $32550.4 and a median of -$1.4 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow soared 29127.52% — and 2025, when it tumbled 1455.79%.
- Tracing MYO's Net Cash Flow over 5 years: stood at $2.9 million in 2021, then tumbled by 171.43% to -$2.1 million in 2022, then surged by 97.07% to -$61261.0 in 2023, then soared by 29127.52% to $17.8 million in 2024, then sank by 109.5% to -$1.7 million in 2025.
- The last three Net Cash Flow figures came in at -$1.7 million (Q3 2025), -$5.6 million (Q2 2025), and -$4.6 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Myomo | 73.79 Mn | 54.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.69 Mn |
| Sep 30, 2025 | -1.69 Mn |
| Jun 30, 2025 | -5.62 Mn |
| Jun 30, 2025 | -5.62 Mn |
| Mar 31, 2025 | -4.61 Mn |
| Mar 31, 2025 | -4.61 Mn |
| Dec 31, 2024 | 17.78 Mn |
| Dec 31, 2024 | 17.78 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 414,711.00 |
| Jun 30, 2024 | 414,711.00 |
| Mar 31, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2023 | -61,261.00 |
| Dec 31, 2023 | -61,261.00 |
| Sep 30, 2023 | 919,384.00 |
| Sep 30, 2023 | 919,384.00 |
| Jun 30, 2023 | -3.26 Mn |
| Jun 30, 2023 | -3.26 Mn |